XML 94 R64.htm IDEA: XBRL DOCUMENT v3.25.1
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]    
Accrued research and development expense $ 1,799,583 $ 1,799,583
Accrued directors and officers (owners) compensation 1,025,867 1,018,253
Accrued royalties 255,592 274,028
Accrued compensation and employee benefits 126,106 29,138
Others 302,274 427,350
Total $ 3,509,422 $ 3,548,352